Effect and safety of meropenem-vaborbactam versus best available therapy in patients with carbapenem-resistant Enterobacteriaceae infections: the TANGO II Randomized Clinical Trial - Wunderink, R G; Giamarellos-Bourboulis, E J; Rahav, G (Infect Dis Ther, 2018)
, et al.